Shares of CVS Group plc (LON:CVSG – Get Free Report) have earned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is GBX 1,666.67.
Several analysts recently weighed in on the company. Jefferies Financial Group increased their price target on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a report on Friday, July 31st. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,000 price target on shares of CVS Group in a research note on Thursday. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,700 price objective on shares of CVS Group in a research report on Monday, July 27th. Finally, Shore Capital Group reaffirmed a “hold” rating and set a GBX 1,400 target price on shares of CVS Group in a research note on Thursday.
View Our Latest Report on CVSG
Insiders Place Their Bets
CVS Group Trading Down 6.5%
Shares of CVSG opened at GBX 1,217.04 on Thursday. The stock has a market capitalization of £827.22 million, a PE ratio of 17.66, a P/E/G ratio of 1.77 and a beta of 1.07. The company’s fifty day moving average is GBX 1,289.88 and its 200 day moving average is GBX 1,230. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. CVS Group has a fifty-two week low of GBX 1,062 and a fifty-two week high of GBX 1,648.
CVS Group (LON:CVSG – Get Free Report) last issued its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. Sell-side analysts expect that CVS Group will post 93.9393939 earnings per share for the current fiscal year.
About CVS Group
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Featured Stories
- Five stocks we like better than CVS Group
- DraftKings Falls 7.6%: Is Kalshi’s NFL Lead Really That Big?
- Gaming Your Portfolio: Should You Add Take-Two Ahead of GTA 6’s November Launch?
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
